Dr. Deborah Dillon

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

DEBORAH DILLON, Staff Pathologist

Address:

Brigham and Women's Hospital, Department of Pathology, 75 Francis Street, Boston, MA

Medical School (including school name, date and degree awarded):

1992 MD, Yale University School of Medicine, New Haven, CT

Graduate Medical Education (including dates and institution of internships, residencies, fellowships, etc.):

1992-95 Resident in Anatomic Pathology, Yale-New Haven Hospital
1995-98 Molecular Pathology Fellow, Yale-New Haven Hospital

Certification (list all):

1997 American Board of Pathology (Anatomic Pathology)
2001 American Board of Pathology and American Board of Genetics
(Molecular Genetic Pathology)

Current Academic Appointment:

Assistant Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointment(s):

Staff Pathologist, Brigham and Women's Hospital

Selected Bibliography:

Dillon, D.A., D'Aquila, T., Reynolds A.B., Fearon, E.R., and Rimm, D.L. The expression of p120ctn protein in breast cancer is independent of [alpha] and [beta]-catenin and E-cadherin. Am J Path 1998;152:75-82.
Dillon, D.A., Johnson, C.C., Topazian, M.D., Tallini, G., Rimm, D.L. and Costa, J.C. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. Cancer J 2000;6:299-306.
Dillon DA, Hipolito E, Zheng K, Rimm DL and Costa JC. p53 mutations as tumor markers in fine-needle aspirates of palpable breast masses. Acta Cytol 2002;46:841-847.
Dillon DA. Molecular markers in the diagnosis and staging of breast cancer. Semin Radiat Oncol 2002;12:305-318.
Dillon DA, Zheng K, Negin B and Costa JC. "Detection of Ki-ras and p53 mutations by laser-capture microdissection/PCR/SSCP" in Laser Capture Microdissection: Methods and Protocols, Murray GI and Curran S, eds. The Humana Press, Inc, Totowa, NJ (2004).